bicalutamide has been researched along with Local Neoplasm Recurrence in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.88) | 18.2507 |
| 2000's | 17 (41.46) | 29.6817 |
| 2010's | 15 (36.59) | 24.3611 |
| 2020's | 7 (17.07) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, T; Koie, T; Miyake, H; Naiki, T; Nakane, K; Shiroki, R; Sugiyama, Y; Takahara, K; Yasui, T | 1 |
| Aaltomaa, S; Ahlgren, G; Andrén, O; Brasso, K; Castellanos, E; Damber, JE; de Wit, R; Holmberg, E; Jellvert, Å; Josefsson, A; Luukkaa, M; Meidahl Petersen, P; Seke, M; Verhagen, P; Widmark, A | 1 |
| Ahmed, HU; Arya, M; Day, E; Dobbs, C; Dudderidge, T; Emberton, M; Fiorentino, F; McCracken, S; Prevost, AT; Reddy, D; Shah, TT; Staffurth, J; Sydes, M; Winkler, M | 1 |
| Babasaki, T; Goto, K; Han, X; Hayashi, T; Inoue, S; Matsubara, A; Sekino, Y; Shiota, M; Takeshima, Y; Teishima, J; Yasui, W | 1 |
| Asioli, S; Fabbri, VP; Palandri, G | 1 |
| Attard, G; Bahary, JP; Dabbas, B; Das, R; Davicioni, E; Dicker, AP; Dignam, JJ; Efstathiou, JA; Feng, FY; Hall, WA; Huang, HC; Liu, YS; Lukka, HR; Margrave, J; Nguyen, PL; Pisansky, TM; Pollack, A; Pugh, SL; Sandler, HM; Shah, AB; Shipley, WU; Simko, JP; Spratt, DE; Sweeney, C; Thompson, DJS; Todorovic, T; Tran, PT; Zhao, SG | 1 |
| Pienta, KJ; Reyes, DK | 1 |
| Black, PC; Struss, WJ | 1 |
| Cornel, EB; Gómez Veiga, F; Persad, R; Schulman, C; Stari, A; Tombal, B | 1 |
| Arai, Y; Habuchi, T; Hoshi, S; Koie, T; Matsuo, S; Mitsuzuka, K; Ohyama, C; Okubo, T; Saito, S; Tsuchiya, N | 1 |
| Bubley, G; Buckle, G; Ernstoff, MS; Kantoff, PW; Morganstern, DE; Nakabayashi, M; Taplin, ME; Walsh, W; Xie, W | 1 |
| Cheng, HH; Fu, ZC; Li, DS; Lin, GS; Luo, HC | 1 |
| Haller, AC; Li, F; Morrison, C; Payne-Ondracek, R; Tan, W; Tian, L; Underwood, W | 1 |
| Hagiwara, M; Hayakawa, N; Ito, Y; Maeda, T; Matsumoto, K; Nagata, H; Nakamura, S; Ninomiya, A; Tanaka, N | 1 |
| Chen, MH; Evan, C; Graham, P; Hirsch, AE; Kantoff, PW; Mahal, BA; Martin, NE; Nakabayashi, M; Nguyen, PL; Parekh, A | 1 |
| Bergamini, C; Bossi, P; Civelli, E; Cortelazzi, B; Dagrada, G; Fallai, C; Licitra, L; Lo Vullo, S; Locati, LD; Perrone, F; Pilotti, S; Potepan, P; Quattrone, P | 1 |
| Bahary, JP; Balogh, AG; Dignam, JJ; Feng, FY; Grignon, DJ; Heney, NM; Kerlin, KJ; Lawton, CA; Lovett, RD; Lukka, HR; Major, PP; Patel, MP; Pisansky, TM; Pugh, SL; Rosenthal, SA; Sandler, HM; Sartor, O; Seiferheld, W; Shipley, WU; Souhami, L; Zeitzer, KL; Zietman, AL | 1 |
| Fujii, M; Fujisawa, M; Ichikawa, T; Kumon, H; Matsuda, T; Matsumoto, T; Miki, T; Miyake, H; Miyoshi, S; Okihara, K; Ozono, S; Suzuki, H; Takihana, Y; Usui, T | 1 |
| Brown, M; Garabedian, MJ; Gerald, WL; Ha, S; Huang, SJ; Logan, SK; Mita, P; Nwachukwu, JC; Ruoff, R; Taneja, SS; Wang, Q | 1 |
| Ahlgren, G; Angelsen, A; Bergh, A; Haugen, OA; Solberg, A; Tasdemir, I; Viset, T; Widmark, A | 1 |
| Higashihara, E; Nutahara, K; Okegawa, T | 1 |
| Habuchi, T; Horikawa, Y; Inoue, T; Kumazawa, T; Maita, S; Nanjyo, H; Narita, S; Numakura, K; Obara, T; Saito, M; Satoh, S; Tsuchiya, N; Tsuruta, H | 1 |
| Both, S; Guzzo, TJ; Haas, NB; Hwang, WT; Jang, JW; Vapiwala, N; Wein, AJ | 1 |
| Chowdhury, S; Davda, R; Khan, A; Payne, H | 1 |
| Tisman, G | 1 |
| Bossi, P; Cantù, G; Licitra, L; Locati, LD; Marchianò, AV; Quattrone, P | 1 |
| Akakura, K; Ichikawa, T; Ito, H; Kojima, S; Shimbo, M; Suzuki, H | 1 |
| Hellerstedt, B | 1 |
| Ferrari, AC; McCarron, JP; Mencher, SK; Wang, LG | 1 |
| Moul, JW; Ward, JF | 2 |
| Fujii, Y; Hyochi, N; Kageyama, Y; Kawakami, S; Kihara, K; Kobayashi, T; Masuda, H | 1 |
| Higashihara, E; Kinjo, M; Nutahara, K; Okegawa, T | 1 |
| Bastian, PJ; Biermann, K; Bollmann, D; Ellinger, J; Müller, SC; Schmidt, ME; Textor, J; Zhou, H | 1 |
| Nemoto, K; Tomita, Y | 1 |
| Aghajanian, C; Derosa, F; Esch, J; Hensley, M; Iasonos, A; Juretzka, M; Konner, J; Levine, D; Lewin, S; Park, K; Sabbatini, P; Spriggs, D | 1 |
| Hyytinen, E; Isola, J; Kallioniemi, OP; Koivisto, P; Palmberg, C; Tammela, T; Visakorpi, T | 1 |
| Andriole, GL; Bhayani, SB | 1 |
| Amin, P; Chen, T; Dawson, N; Engstrom, C; Hussain, A; Naslund, M | 1 |
| Haapala, K; Helin, HJ; Hyytinen, ER; Koivisto, PA; Laurila, M; Rantala, I; Roiha, M | 1 |
| Martorana, G | 1 |
6 review(s) available for bicalutamide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Third-line hormonal therapy to treat prostate cancer relapse after initial and second-line hormonal therapy: report of 52 cases and literature review.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chlormadinone Acetate; Cohort Studies; Flutamide; Gonadotropin-Releasing Hormone; Humans; Kallikreins; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Tosyl Compounds; Treatment Outcome | 2014 |
Hormone therapy for radiorecurrent prostate cancer.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Gynecomastia; Humans; Male; Mastodynia; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy; Recurrence; Risk Factors; Tosyl Compounds; Treatment Failure; Treatment Outcome | 2013 |
Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Diethylstilbestrol; Disease-Free Survival; Drug Administration Schedule; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Male; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Salvage Therapy; Tosyl Compounds; Treatment Outcome | 2003 |
Biochemical recurrence after definitive prostate cancer therapy. Part II: treatment strategies for biochemical recurrence of prostate cancer.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Cryotherapy; Disease Progression; Humans; Male; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment; Salvage Therapy; Tosyl Compounds | 2005 |
Treating the biochemical recurrence of prostate cancer after definitive primary therapy.
Topics: Androgen Antagonists; Anilides; Cryotherapy; Disease-Free Survival; Humans; Male; Neoplasm Recurrence, Local; Nitriles; Prognosis; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Salvage Therapy; Tosyl Compounds | 2005 |
Hormonal manipulation for rising PSA after radical prostatectomy.
Topics: Androgen Antagonists; Anilides; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Flutamide; Humans; Male; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds | 1999 |
11 trial(s) available for bicalutamide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14).
Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Disease-Free Survival; Docetaxel; Hormones; Humans; Male; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 2023 |
Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control Trial.
Topics: Ablation Techniques; Androgen Antagonists; Anilides; Brachytherapy; Costs and Cost Analysis; Equivalence Trials as Topic; Finasteride; Humans; Male; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nitriles; Progression-Free Survival; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Research Design; Tosyl Compounds; United Kingdom | 2020 |
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.
Topics: Aged; Anilides; Follow-Up Studies; Genomics; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds | 2021 |
Commentary on: Radiation With or Without Antiandrogen Therapy in Recurrent Prostate Cancer.
Topics: Aged; Androgen Antagonists; Anilides; Clinical Trials as Topic; Cohort Studies; Double-Blind Method; Drug Administration Schedule; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Radiotherapy; Research Design; Tosyl Compounds; Treatment Outcome | 2017 |
Clinical Outcomes and Testosterone Levels Following Continuous Androgen Deprivation in Patients with Relapsing or Locally Advanced Prostate Cancer: A Post Hoc Analysis of the ICELAND Study.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Leuprolide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tosyl Compounds; Treatment Outcome | 2017 |
Two years of bicalutamide monotherapy in patients with biochemical relapse after radical prostatectomy.
Topics: Aged; Anilides; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Proportional Hazards Models; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Salvage Therapy; Tosyl Compounds; Treatment Failure | 2018 |
Long-term follow-up of a phase II trial of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Therapy, Combination; Estramustine; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostatic Neoplasms; Retrospective Studies; Taxoids; Time Factors; Tosyl Compounds; Treatment Outcome | 2013 |
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Gynecomastia; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Survival Rate; Tosyl Compounds | 2017 |
Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biopsy; Combined Modality Therapy; Disease Progression; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Nitriles; Odds Ratio; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 2011 |
A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.
Topics: Adult; Aged; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Goserelin; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Ovarian Neoplasms; Tosyl Compounds | 2007 |
Docetaxel followed by hormone therapy after failure of definitive treatments for clinically localized/locally advanced prostate cancer: preliminary results.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Docetaxel; Finasteride; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Paclitaxel; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Salvage Therapy; Taxoids; Tosyl Compounds | 2001 |
24 other study(ies) available for bicalutamide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Comparison of clinical outcomes between androgen deprivation therapy with up-front abiraterone and bicalutamide for Japanese patients with LATITUDE high-risk prostate cancer in a real-world retrospective analysis.
Topics: Abiraterone Acetate; Androgen Antagonists; Androgens; Androstenes; Anilides; Antineoplastic Combined Chemotherapy Protocols; Humans; Japan; Male; Neoplasm Recurrence, Local; Nitriles; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Tosyl Compounds | 2022 |
Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Biomarkers, Tumor; Cell Line, Tumor; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Knockout Techniques; Humans; Kallikreins; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Nitriles; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; PTEN Phosphohydrolase; Receptors, Androgen; Retrospective Studies; tau Proteins; Tosyl Compounds | 2020 |
An unusual case of "sterile" abscess within low-grade meningioma during anti androgenic therapy and LH-releasing hormone agonist treatment for prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Brain Abscess; Combined Modality Therapy; Craniotomy; Hearing Loss, Unilateral; Humans; Incidental Findings; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Necrosis; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Neuroimaging; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2020 |
Peripheral androgen blockade in men with castrate-sensitive biochemical recurrent prostate cancer.
Topics: Aged; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Finasteride; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostatic Neoplasms, Castration-Resistant; Tosyl Compounds | 2021 |
Intensity-modulated radiotherapy combined with endocrine therapy for intermediate and advanced prostate cancer: long-term outcome of Chinese patients.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cystitis; Follow-Up Studies; Goserelin; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Proctitis; Prognosis; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Survival Rate; Tosyl Compounds | 2013 |
High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Disease Progression; Disease-Free Survival; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prognosis; Prostatectomy; Prostatic Neoplasms; Proto-Oncogene Proteins c-ets; Receptors, Androgen; Tosyl Compounds; Treatment Outcome | 2014 |
Role of androgen deprivation therapy in early salvage radiation among patients with prostate-specific antigen level of 0.5 or less.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Salvage Therapy; Tosyl Compounds; Treatment Outcome | 2015 |
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.
Topics: Adult; Aged; Androgen Antagonists; Anilides; Biomarkers; DNA Mutational Analysis; ErbB Receptors; Female; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Receptors, Androgen; Retrospective Studies; Salivary Gland Neoplasms; Survival Analysis; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate | 2016 |
Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Flutamide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Survival Analysis; Tosyl Compounds; Treatment Outcome | 2008 |
Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells.
Topics: Androgen Antagonists; Androgens; Anilides; Cell Cycle Proteins; Cell Growth Processes; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Male; Molecular Chaperones; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Tosyl Compounds | 2009 |
Alternative antiandrogen therapy in patients with castration-resistant prostate cancer: a single-center experience.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Cohort Studies; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Therapy, Combination; Flutamide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Risk Assessment; Survival Analysis; Tosyl Compounds; Treatment Failure | 2010 |
Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized p
Topics: Aged; Androgens; Anilides; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Estramustine; Female; Follow-Up Studies; Humans; Leuprolide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Survival Rate; Taxoids; Tosyl Compounds; Treatment Outcome | 2012 |
Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA.
Topics: Analysis of Variance; Androgen Antagonists; Anilides; Combined Modality Therapy; Disease-Free Survival; Flutamide; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy Dosage; Retrospective Studies; Salvage Therapy; Seminal Vesicles; Tosyl Compounds | 2012 |
Unusual anti-angiogenic effect of combined hormonal blockade.
Topics: Aged; Angiogenesis Inhibitors; Anilides; Antineoplastic Agents, Hormonal; Capillaries; Chemotherapy, Adjuvant; Drug Therapy, Combination; Finasteride; Humans; Leuprolide; Male; Neoplasm Recurrence, Local; Nitriles; Prostatic Neoplasms; Skin; Telangiectasis; Tosyl Compounds; Treatment Outcome | 2002 |
A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Nitriles; Parotid Gland; Parotid Neoplasms; Radiotherapy, Adjuvant; Receptors, Androgen; Risk Assessment; Skin Ulcer; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate | 2003 |
Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapy.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Flutamide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostatic Neoplasms; Substance Withdrawal Syndrome; Survival Rate; Tosyl Compounds; Treatment Failure | 2004 |
The biological basis for the use of an anti-androgen and a 5-alpha-reductase inhibitor in the treatment of recurrent prostate cancer: Case report and review.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Drug Synergism; Enzyme Inhibitors; Finasteride; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Phosphorylation; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds; Tumor Cells, Cultured | 2004 |
Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2006 |
Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Biomarkers, Tumor; Bone Neoplasms; Disease-Free Survival; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Receptor, ErbB-2; Retrospective Studies; Survival Rate; Tosyl Compounds; Treatment Outcome | 2006 |
Prostate cancer tissue is masked by bicalutamide: a case report.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Biopsy, Needle; Humans; Immunohistochemistry; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nitriles; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds | 2007 |
Neuroendocrine differentiation of localized prostate cancer during endocrine therapy.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Cell Differentiation; Goserelin; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 2007 |
Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade.
Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Androgen Antagonists; Androgen Receptor Antagonists; Anilides; Biomarkers, Tumor; DNA, Neoplasm; Endosonography; Follow-Up Studies; Gene Amplification; Humans; In Situ Hybridization, Fluorescence; Male; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds | 1997 |
Androgen receptor alterations in prostate cancer relapsed during a combined androgen blockade by orchiectomy and bicalutamide.
Topics: Androgen Antagonists; Anilides; Combined Modality Therapy; Humans; Male; Mutation; Neoplasm Recurrence, Local; Nitriles; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds | 2001 |
[Adjuvant hormone therapy in prostatic cancer: after treatment with curative intent. The viewpoint of the urologist].
Topics: Adult; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Chemotherapy, Adjuvant; Clinical Trials as Topic; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Time Factors; Tosyl Compounds | 2002 |